HR Execs on the Move

Carta Healthcare

www.carta.healthcare

 
Carta empowers hospitals to personalize the delivery of care to the individual needs of each patient. Our insight here is that personalizing care is not only good from an outcome/clinical perspective (where most people focus in the context of personalization) but is also the best way to optimize operations. Currently, hospitals have to over provision their resources because they are set up to serve the generic patient; planning ahead for exactly the resources needed– no more, no less– is the best way to gain efficiency. The approach we`re advocating and enabling is to: 1) Find past patients similar to the ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Sean Hurley
Vice President of Sales Enablement and Profile

Similar Companies

AcelRx

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.

Hialeah Hospital

Hialeah Hospital is a 378-bed acute care facility with an experienced medical staff of more than 900 employees. Since we first opened our doors in 1951, we have provided compassionate care to our neighbors and their friends and families. Because we know hospital trips are especially challenging for our elderly neighbors, we provide specially designed senior services including a Senior ER and an Acute Care for the Elderly (ACE) Unit.

PeerBridge Health

Peerbridge Health, Inc. is a mobile health IT company seeking to bring independence and precision with remote monitoring capabilities for medical, wellness and performance-based needs including the monitoring of vital signs, with thoughtful design and a seamless user experience.

NorthStar Clinical Communications

NorthStar Clinical Communications is a Washington Crossing, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

BeneFit Cosmetics

BeneFit Cosmetics LLC is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. BeneFit Cosmetics LLC is based in San Francisco, CA. You can find more information on BeneFit Cosmetics LLC at www.benefitcosmetics.com